TerrAscend (TSNDF) vs. Its Rivals Head-To-Head Review

TerrAscend (OTCMKTS:TSNDF) is one of 43 public companies in the “Agricultural production – crops” industry, but how does it weigh in compared to its rivals? We will compare TerrAscend to related companies based on the strength of its dividends, valuation, risk, institutional ownership, analyst recommendations, profitability and earnings.

Volatility and Risk

TerrAscend has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s rivals have a beta of -19.60, suggesting that their average stock price is 2,060% less volatile than the S&P 500.

Profitability

This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-23.95%	-31.48%	-11.40%
TerrAscend Competitors	-98.15%	-2,439.03%	-14.56%

Insider and Institutional Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for TerrAscend and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	1	3.00
TerrAscend Competitors	315	258	605	34	2.30

As a group, “Agricultural production – crops” companies have a potential upside of 52.71%. Given TerrAscend’s rivals higher possible upside, analysts clearly believe TerrAscend has less favorable growth aspects than its rivals.

Earnings & Valuation

This table compares TerrAscend and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TerrAscend	$317.33 million	-$95.54 million	-1.68
TerrAscend Competitors	$1.22 billion	-$827,419.35	6.95

TerrAscend’s rivals have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend beats its rivals on 7 of the 13 factors compared.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.